恒瑞医药(01276.HK)：二十碳五烯酸乙酯软胶囊获批上市

Core Viewpoint - Heng Rui Medicine (01276.HK) announced the approval of its subsidiary Chengdu Shengdi Pharmaceutical Co., Ltd. for the launch of Eicosapentaenoic Acid Ethyl Ester Soft Capsules by the National Medical Products Administration [1] Group 1: Product Approval - The product is indicated for lowering triglyceride (TG) levels in adult patients with severe hypertriglyceridemia (≥500 mg/dL) on a controlled diet [1] - It is also used in combination with statins for adult patients diagnosed with cardiovascular diseases or diabetes with ≥2 other cardiovascular disease risk factors, who have hypertriglyceridemia (≥150 mg/dL), to reduce the risk of cardiovascular events [1]